\n| \n (in millions, except per share data)<\/i><\/b><\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n Three Months Ended<\/b><\/p>\n Sept. 30, 2024<\/b><\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n Fiscal Year Ended<\/b><\/p>\n Sept. 30, 2024<\/b><\/p>\n<\/td>\n<\/tr>\n\n| \n \nRevenue<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n$<\/p>\n<\/td>\n | \n \n208.8<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n$<\/p>\n<\/td>\n | \n \n1,117.4<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n<\/tr>\n | \n| \n \nOperating loss<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n(29.8<\/p>\n<\/td>\n | \n \n)<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n(116.8<\/p>\n<\/td>\n | \n \n)<\/p>\n<\/td>\n<\/tr>\n | \n| \n \nAdjusted operating (loss) earnings*<\/sup><\/p>\n<\/td>\n| \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n(12.8<\/p>\n<\/td>\n | \n \n)<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n93.2<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n<\/tr>\n | \n| \n \nAdjusted EBITDA*<\/sup><\/p>\n<\/td>\n| \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n15.6<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n206.3<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n<\/tr>\n | \n| \n \nNet loss<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n(48.3<\/p>\n<\/td>\n | \n \n)<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n(206.1<\/p>\n<\/td>\n | \n \n)<\/p>\n<\/td>\n<\/tr>\n | \n| \n \nNet (loss) earnings per diluted share<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n(1.17<\/p>\n<\/td>\n | \n \n)<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n(4.99<\/p>\n<\/td>\n | \n \n)<\/p>\n<\/td>\n<\/tr>\n | \n| \n \nAdjusted net (loss) earnings*<\/sup><\/p>\n<\/td>\n| \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n(31.5<\/p>\n<\/td>\n | \n \n)<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n3.7<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n<\/tr>\n | \n| \n \nAdjusted net (loss) earnings*<\/sup> per diluted share<\/p>\n<\/td>\n| \n \n\u00a0<\/p>\n<\/td>\n | \n \n$<\/p>\n<\/td>\n | \n \n(0.77<\/p>\n<\/td>\n | \n \n)<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n$<\/p>\n<\/td>\n | \n \n0.08<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n<\/tr>\n<\/table>\n \n* Non-GAAP financial measure. Reconciliations to the most directly comparable GAAP financial measure are provided in tables at the end of this press release.<\/p>\n SALT BUSINESS SUMMARY<\/span><\/b><\/p>\n\nSalt segment fiscal 2024 fourth-quarter revenue totaled $162.5 million, down 13% year over year, due to a 21% decrease in total sales volumes offset by a 10% increase in price. Fourth-quarter sales volumes year over year saw meaningful declines in highway deicing product and modest declines in consumer and industrial (C&I) salt product. Lower prefill activity in the highway deicing business in the fourth quarter of 2024 resulted in C&I representing a larger share of the sales volume mix relative to 2024, resulting in a 10% increase in total pricing for the Salt business despite 3% and 4% increases in price per ton for highway deicing and C&I products, respectively. Quarterly distribution costs per ton increased 12% year over year, while all-in product costs (defined at the segment level as sales to external customers less distribution costs less operating earnings) per ton increased 13% year over year. Operating earnings decreased 27% to $21.0 million, while adjusted EBITDA declined 14% to $38.1 million from the prior-year period.<\/p>\n \nFor the fiscal full-year 2024, Salt segment revenue was down 10% year over year to $907.8 million. This was driven by one of the weakest highway deicing seasons in the last quarter century, leading to a 20% decrease in highway deicing sales volumes. C&I sales volumes, which include consumer deicing products, were also down 7%. Higher prices for highway deicing salt (up 6%) and C&I salt (also up 6%) led to an overall 9% increase in Salt pricing year over year. The Salt segment generated $163.6 million in operating earnings and adjusted EBITDA of $228.2 million, down 4% and 1%, respectively, year over year. The company saw improvements to adjusted EBITDA margin year over year, which improved by over 200 basis points from prior year levels. Adjusted EBITDA per ton also improved to approximately $24.50 per ton in fiscal 2024, which is a 20% improvement from 2023 levels.<\/p>\n PLANT NUTRITION BUSINESS SUMMARY<\/span><\/b><\/p>\n\nPlant Nutrition segment fourth-quarter revenue totaled $42.4 million, up 20% year over year, driven by a 33% increase in sales volumes offset by a 10% decrease in price. Global dynamics within the broader potash-based fertilizer markets have continued to pressure prices downward, which has a direct impact on the company’s sulfate of potash (SOP) products.<\/p>\n \nFor the fourth quarter, distribution costs per ton decreased 9% year over year due to more sales volumes being available to absorb fixed distribution costs. Reported all-in product costs per ton, which include the aforementioned non-cash impairment associated with certain water rights in Utah, increased 48% year over year. Excluding the impairment, all-in product costs per ton increased 8% over the prior-year period. The segment had an operating loss of $29.7 million for the quarter, down from a $3.3 million operating loss the corresponding period last year. Adjusted EBITDA declined over the same period $8.7 million to a loss of $3.7 million.<\/p>\n \nFor the full fiscal year, the segment grew revenue 5% to $181.0 million in revenue, due to a 25% increase in sales volumes partially offset by a decline in sales price year over year. The increase in sales volumes reflects the normalization of demand in the company’s core West Coast markets following extraordinary prior-year weather events in select key markets. Distribution costs per ton decreased 7% year over year. Reported all-in product costs per ton increased 38% to $889.38 year over year. These results include $68.6 million of non-cash impairments, including $51.0 million recognized in the second quarter related to revisions of the outlook to the Plant Nutrition business as well as the aforementioned write down related to certain of the company’s water rights. Excluding adjustments, all-in operating costs per ton were flat year over year. The segment had an operating loss of $86.4 million and adjusted EBITDA of $16.9 million for the full year.<\/p>\n FIRE RETARDANT BUSINESS UPDATE<\/span><\/b><\/p>\n\nCompass Minerals continues to evaluate various alternatives regarding the path forward for Fortress North America (Fortress). Discussions are ongoing with the U.S. Forest Service (USFS) regarding the evaluation and testing of the company’s non-magnesium chloride-based aerial fire retardants.<\/p>\n CASH FLOW AND FINANCIAL POSITION<\/span><\/b><\/p>\n\nNet cash provided by operating activities amounted to $14.4 million for fiscal 2024, down from $106.0 million in the prior year. The change year over year reflects the impact of an exceptionally mild winter in 2024 and increases in working capital balances.<\/p>\n \nNet cash used in investing activities was $116.1 million for fiscal 2024, down $61.8 million year over year. The prior year activity reflects higher capital investment, including $48.5 million in capital expenditures related to the company’s now-terminated lithium salt development as well as its investment to purchase the remaining 55% of Fortress it did not previously own. Capital expenditures for fiscal 2024 were $114.2 million, including approximately $20.2 million related to the company’s terminated lithium project.<\/p>\n \nNet cash provided by financing activities was $83.1 million for fiscal 2024, compared to $64.0 million in the comparable prior-year period. Current year activities include net borrowings of $111.6 million, dividends paid on common stock of $12.6 million, and contingent consideration payments related to Fortress of $9.1 million. In the prior year, net cash provided by financing activities reflected the proceeds from a private placement of common stock and the pay down of a portion of outstanding debt.<\/p>\n \nThe company ended the fiscal year with $189.9 million of liquidity, comprised of $20.2 million in cash and cash equivalents and $169.7 million of availability under its $375 million revolving credit facility. At quarter-end, the consolidated total net leverage ratio was 4.9 times, within the company’s net leverage covenant of 6.5 times.<\/p>\n FISCAL 2025 OUTLOOK<\/span><\/b><\/p>\n\n- \nSalt sales volumes for 2025 at the midpoint of guidance are expected to increase approximately 9% over 2024, assuming average sales-to-commitment ratios;<\/p>\n<\/li>\n
- \nCompleted 2024-2025 bid season resulted in North American highway deicing prices down approximately 2% and committed volumes down roughly 9%; and<\/p>\n<\/li>\n
- \nPlant Nutrition earnings expected to be in line with 2024 levels while efforts continue to restore the business, driven by lower SOP pricing offset by improving volumes and lower forecasted production costs.<\/p>\n<\/li>\n<\/ul>\n
\n\n| \n Salt Segment Range of Outcomes<\/b><\/p>\n<\/td>\n<\/tr>\n\n| \n \n\u00a0<\/p>\n<\/td>\n | \n 2025 Range1<\/sup><\/b><\/p>\n<\/td>\n<\/tr>\n\n| \n \nHighway deicing sales volumes (thousands of tons)<\/i><\/p>\n<\/td>\n | \n \n7,800 – 8,700<\/p>\n<\/td>\n<\/tr>\n | \n| \n \nConsumer and industrial sales volumes (thousands of tons)<\/i><\/p>\n<\/td>\n | \n \n1,850 – 2,000<\/p>\n<\/td>\n<\/tr>\n | \n| \n \nTotal salt sales volumes (thousands of tons)<\/i><\/p>\n<\/td>\n | \n \n9,650 – 10,700<\/p>\n<\/td>\n<\/tr>\n | \n| \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n<\/tr>\n | \n| \n \nRevenue (in millions)<\/i><\/p>\n<\/td>\n | \n \n$940 – $1,040<\/p>\n<\/td>\n<\/tr>\n | \n| \n \nAdj. EBITDA (in millions)<\/i><\/p>\n<\/td>\n | \n \n$225 – $250<\/p>\n<\/td>\n<\/tr>\n<\/table>\n \n\n| (1)<\/td>\n | \n \nRange for fiscal 2025 reflects the company’s committed book of business for the period and assumes an average historical sales-to-commitment outcomes.<\/p>\n<\/td>\n<\/tr>\n<\/table>\n \nConsistent with the results disclosed in the company’s third-quarter fiscal 2024 results, the average contract price for the upcoming North American winter season is expected to be approximately 2% below the prior year’s bid season results while total committed bid volumes will decrease by approximately 9% compared to prior-year bid season. It is important to distinguish between committed bid volumes, which are used to establish minimum and maximum service levels for certain customers, and expected sales volumes, which will be driven ultimately by winter weather activity in the coming year. Sales volumes can be above or below committed volumes in any given deicing season.<\/p>\n \nWhile demand for deicing salt is stable over time, the nature of winter weather and the manner in which customers respond to weather events make forecasting deicing sales volumes difficult during any single year. Therefore, the company has provided a guidance range that is informed by a historical average of sales to commitment ratios.<\/p>\n \nCompass Minerals expects that approximately 75% of its highway deicing sales will be achieved in the first half of the fiscal year.<\/p>\n \nThe company will continue to focus in fiscal 2025 on reducing Salt segment inventory across the platform and then align production levels with anticipated demand based on the results of North American highway deicing season.<\/p>\n \n\n| \n Plant Nutrition Segment Guidance<\/b><\/p>\n<\/td>\n<\/tr>\n\n| \n \n\u00a0<\/p>\n<\/td>\n | \n 2025 Range<\/b><\/p>\n<\/td>\n<\/tr>\n\n| \n \nSales volumes (thousands of tons)<\/i><\/p>\n<\/td>\n | \n \n285 – 305<\/p>\n<\/td>\n<\/tr>\n | \n| \n \nRevenue (in millions)<\/i><\/p>\n<\/td>\n | \n \n$175 – $195<\/p>\n<\/td>\n<\/tr>\n | \n| \n \nAdj. EBITDA (in millions)<\/i><\/p>\n<\/td>\n | \n \n$14 – $20<\/p>\n<\/td>\n<\/tr>\n<\/table>\n \nThe company expects a modest increase in sales volumes in 2025 as economic conditions in certain key markets are anticipated to improve. SOP prices are expected to decline year over year as a result of anticipated weakness in global potash prices. Operationally, the focus of the Plant Nutrition segment in 2025 is on the restoration of the company’s Ogden ponds and advancing efficiency initiatives at the plant. These efforts include using an optimized amount of potassium chloride in the production of SOP at our Ogden production site that reduce harvest demands on the pond system.<\/p>\n \n\n| \n Corporate<\/b><\/p>\n<\/td>\n<\/tr>\n\n| \n \n\u00a0<\/p>\n<\/td>\n | \n 2025 Range<\/b><\/p>\n<\/td>\n<\/tr>\n\n| \n \n\u00a0<\/p>\n<\/td>\n | \n Total1<\/sup><\/b><\/p>\n<\/td>\n<\/tr>\n\n| \n \nAdj. EBITDA (in millions)<\/i><\/p>\n<\/td>\n | \n \n($70) – ($61)<\/p>\n<\/td>\n<\/tr>\n<\/table>\n \n\n| (1)<\/td>\n | \n \nIncludes $3 to $5 million in cash expenses related to Fortress.<\/p>\n<\/td>\n<\/tr>\n<\/table>\n \nProjected Corporate segment results shown in the table above include corporate expenses in support of our core businesses, Fortress financial results, and the results of DeepStore, the company’s records and management services business in the U.K. The guidance above does not include any revenue that could arise from a fire-retardant contract resulting from ongoing negotiations with the USFS.<\/p>\n \n\n| \n Total Compass Minerals<\/b><\/p>\n<\/td>\n<\/tr>\n\n| \n \n\u00a0<\/p>\n<\/td>\n | \n 2025 Adjusted EBITDA<\/b><\/p>\n<\/td>\n<\/tr>\n\n| \n \n\u00a0<\/p>\n<\/td>\n | \n Salt<\/b><\/p>\n<\/td>\n | \n Plant Nutrition<\/b><\/p>\n<\/td>\n | \n Corporate1<\/sup><\/b><\/p>\n<\/td>\n| \n Total<\/b><\/p>\n<\/td>\n<\/tr>\n\n| \n \nAdj. EBITDA (in millions)<\/i><\/p>\n<\/td>\n | \n \n$225 – $250<\/p>\n<\/td>\n | \n \n$14 – $20<\/p>\n<\/td>\n | \n \n($70) – ($61)<\/p>\n<\/td>\n | \n \n$169 – $209<\/p>\n<\/td>\n<\/tr>\n | \n| \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n<\/tr>\n | \n| \n \n\u00a0<\/p>\n<\/td>\n | \n 2025 Capital Expenditures<\/b><\/p>\n<\/td>\n<\/tr>\n\n| \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n Total<\/b><\/p>\n<\/td>\n<\/tr>\n\n| \n \nCapital expenditures (in millions<\/i>)<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n$100 – $110<\/p>\n<\/td>\n<\/tr>\n<\/table>\n \n\n| (1)<\/td>\n | \n \nIncludes financial contribution from DeepStore and Fortress.<\/p>\n<\/td>\n<\/tr>\n<\/table>\n \nTotal capital expenditures for the company in fiscal 2025 are expected to be within a range of $100 million to $110 million. This includes non-recurring amounts of $10 million to $15 million for larger capital projects, including preparation work for the mill relocation at Goderich mine and refurbishment of silos at Ogden. The capital program is scheduled in a manner that would allow scaling back of expenditures in the back half of the year in the event of a mild winter.<\/p>\n \n\n| \n Other Assumptions<\/b><\/p>\n<\/td>\n<\/tr>\n\n| \n ($ in millions)<\/i><\/p>\n<\/td>\n | \n 2025 Range<\/b><\/p>\n<\/td>\n<\/tr>\n\n| \n \nDepreciation, depletion and amortization<\/p>\n<\/td>\n | \n \n$105 – $115<\/p>\n<\/td>\n<\/tr>\n | \n| \n \nInterest expense, net<\/p>\n<\/td>\n | \n \n$67 – $72<\/p>\n<\/td>\n<\/tr>\n | \n| \n \nEffective income tax rate (excl. valuation allowance)<\/p>\n<\/td>\n | \n \n(295%) – (290%)<\/p>\n<\/td>\n<\/tr>\n<\/table>\n \nThe guidance for the 2025 effective income tax rate reflects the income mix by country with income recognized in foreign jurisdictions offset by losses recognized in the U.S.<\/p>\n CONFERENCE CALL<\/span><\/b><\/p>\n\nCompass Minerals will discuss its results on a conference call tomorrow morning, Tuesday, Dec. 17, at 10:00 a.m. ET. To access the conference call, please visit the company\u2019s website at investors.compassminerals.com or dial 800-715-9871. Callers must provide the conference ID number 7896827. Outside of the U.S. and Canada, callers may dial 646-307-1963. Replays of the call will be available on the company\u2019s website.<\/p>\n \nA corporate presentation with fiscal 2024 results is available at investors.compassminerals.com.<\/p>\n About Compass Minerals<\/b><\/p>\n \nCompass Minerals (NYSE: CMP) is a leading global provider of essential minerals focused on safely delivering where and when it matters to help solve nature\u2019s challenges for customers and communities. The company\u2019s salt products help keep roadways safe during winter weather and are used in numerous other consumer, industrial, chemical and agricultural applications. Its plant nutrition products help improve the quality and yield of crops, while supporting sustainable agriculture. Additionally, it is working to develop a long-term fire-retardant business. Compass Minerals operates 12 production and packaging facilities with nearly 2,000 employees throughout the U.S., Canada and the U.K. Visit compassminerals.com for more information about the company and its products.<\/p>\n Forward-Looking Statements and Other Disclaimers<\/span><\/b><\/p>\nThis press release may contain forward-looking statements, including, without limitation, statements about cash generation capability; debt reduction; value creation; expectations for Fortress; the company’s outlook for 2025, including its expectations regarding pricing, sales volumes, revenue, corporate and other expense, depreciation, depletion and amortization, interest expense, tax rates, capital expenditures, operating expenses, and Adjusted EBITDA. Forward-looking statements are those that predict or describe future events or trends and that do not relate solely to historical matters. We use words such as \u201cmay,\u201d \u201cwould,\u201d \u201ccould,\u201d \u201cshould,\u201d \u201cwill,\u201d \u201clikely,\u201d \u201cexpect,\u201d \u201canticipate,\u201d \u201cbelieve,\u201d \u201cintend,\u201d \u201cplan,\u201d \u201cforecast,\u201d \u201coutlook,\u201d \u201cproject,\u201d \u201cestimate\u201d and similar expressions suggesting future outcomes or events to identify forward-looking statements or forward-looking information. These statements are based on the company\u2019s current expectations and involve risks and uncertainties that could cause the company\u2019s actual results to differ materially. The differences could be caused by a number of factors, including without limitation (i) weather conditions, (ii) inflation, the cost and availability of transportation for the distribution of the company\u2019s products and foreign exchange rates, (iii) pressure on prices and impact from competitive products, (iv) any inability by the company to successfully implement its strategic priorities or its cost-saving or enterprise optimization initiatives, and (v) the risk that the company may not realize the intended financial or other benefits from, or that it may incur unexpected costs in connection with, its ownership of Fortress North America. For further information on these and other risks and uncertainties that may affect the company\u2019s business, see the \u201cRisk Factors\u201d and \u201cManagement\u2019s Discussion and Analysis of Financial Condition and Results of Operations\u201d sections of the company\u2019s Annual Report on Form 10-K for the period ended Sept. 30, 2024, its Amended Quarterly Reports on Form 10-Q\/A for the quarters ended Dec. 31, 2023 and Mar. 31, 2024, and its Quarterly Report on Form 10-Q for the quarter ended June 30, 2024 filed or to be filed with the SEC, as well as the company’s other SEC filings. The company undertakes no obligation to update any forward-looking statements made in this press release to reflect future events or developments, except as required by law. Because it is not possible to predict or identify all such factors, this list cannot be considered a complete set of all potential risks or uncertainties.<\/i><\/p>\n Non-GAAP Measures<\/b><\/p>\n In addition to using U.S. generally accepted accounting principles (\u201cGAAP\u201d) financial measures, management uses a variety of non-GAAP financial measures described below to evaluate the company\u2019s and its operating segments\u2019 performance. While the consolidated financial statements provide an understanding of the company\u2019s overall results of operations, financial condition and cash flows, management analyzes components of the consolidated financial statements to identify certain trends and evaluate specific performance areas.<\/i><\/p>\n Management uses EBITDA, EBITDA adjusted for items which management believes are not indicative of the company\u2019s ongoing operating performance (\u201cAdjusted EBITDA\u201d) and EBITDA margin to evaluate the operating performance of the company\u2019s core business operations because its resource allocation, financing methods and cost of capital, and income tax positions are managed at a corporate level, apart from the activities of the operating segments, and the operating facilities are located in different taxing jurisdictions, which can cause considerable variation in net earnings. Management also uses adjusted operating earnings, adjusted operating margin, adjusted net earnings, and adjusted net earnings per diluted share, which eliminate the impact of certain items that management does not consider indicative of underlying operating performance. The presentation of these measures should not be construed as an inference that future results will be unaffected by unusual or non-recurring items. Management believes these non-GAAP financial measures provide management and investors with additional information that is helpful when evaluating underlying performance. EBITDA and Adjusted EBITDA exclude interest expense, income taxes and depreciation, depletion and amortization, each of which are an essential element of the company\u2019s cost structure and cannot be eliminated. In addition, Adjusted EBITDA and Adjusted EBITDA margin exclude certain cash and non-cash items, including stock-based compensation. Consequently, any measure that excludes these elements has material limitations. The non-GAAP financial measures used by management should not be considered in isolation or as a substitute for net earnings, operating earnings, cash flows or other financial data prepared in accordance with GAAP or as a measure of overall profitability or liquidity. These measures are not necessarily comparable to similarly titled measures of other companies due to potential inconsistencies in the method of calculation. The calculation of non-GAAP financial measures as used by management is set forth in the following tables. All margin numbers are defined as the relevant measure divided by sales. The company does not provide a reconciliation of forward-looking non-GAAP financial measures to the most directly comparable financial measures calculated and reported in accordance with GAAP, as the company is unable to estimate significant non-recurring or unusual items without unreasonable effort. The amounts and timing of these items are uncertain and could be material to the company\u2019s results.<\/i><\/p>\n Adjusted operating earnings, adjusted operating earnings margin, adjusted net (loss) earnings, and adjusted net (loss) earnings per diluted share are presented as supplemental measures of the company\u2019s performance. Management believes these measures provide management and investors with additional information that is helpful when evaluating underlying performance and comparing results on a year-over-year normalized basis. These measures eliminate the impact of certain items that management does not consider indicative of underlying operating performance. These adjustments are itemized below. Adjusted net (loss) earnings per diluted share is adjusted net (loss) earnings divided by weighted average diluted shares outstanding. You are encouraged to evaluate the adjustments itemized above and the reasons management considers them appropriate for supplemental analysis. In evaluating these measures you should be aware that in the future the company may incur expenses that are the same as or similar to some of the adjustments presented below.<\/i><\/p>\n\n\n| \n Special Items Impacting the Three Months Ended Sept. 30, 2024<\/b><\/p>\n (unaudited, in millions, except per share data)<\/i><\/p>\n<\/td>\n<\/tr>\n\n| \n Item Description<\/b><\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n Segment<\/b><\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n Line Item<\/b><\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n Amount<\/b><\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n Tax Effect(1)<\/sup><\/b><\/p>\n<\/td>\n| \n \n\u00a0<\/p>\n<\/td>\n | \n After Tax<\/b><\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n EPS Impact<\/b><\/p>\n<\/td>\n<\/tr>\n\n| \n \nRestructuring charges(2)<\/sup><\/p>\n<\/td>\n| \n \n\u00a0<\/p>\n<\/td>\n | \n \nCorporate and Other<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \nOther operating expense<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n$<\/p>\n<\/td>\n | \n \n(1.4<\/p>\n<\/td>\n | \n \n)<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n$<\/p>\n<\/td>\n | \n \n\u2014<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n$<\/p>\n<\/td>\n | \n \n(1.4<\/p>\n<\/td>\n | \n \n)<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n$<\/p>\n<\/td>\n | \n \n(0.04<\/p>\n<\/td>\n | \n \n)<\/p>\n<\/td>\n<\/tr>\n | \n| \n \nImpairments<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \nPlant Nutrition<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \nLoss on impairments<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n17.6<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u2014<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n17.6<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n0.43<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n<\/tr>\n | \n| \n \nProvision for product recall costs<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \nSalt<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \nOther operating expense<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n0.8<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n(0.2<\/p>\n<\/td>\n | \n \n)<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n0.6<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n0.01<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n<\/tr>\n | \n| \n \nTotal<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n$<\/p>\n<\/td>\n | \n \n17.0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n$<\/p>\n<\/td>\n | \n \n(0.2<\/p>\n<\/td>\n | \n \n)<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n$<\/p>\n<\/td>\n | \n \n16.8<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n$<\/p>\n<\/td>\n | \n \n0.40<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n<\/tr>\n<\/table>\n \n\n| \n Special Items Impacting the Three Months Ended Sept. 30, 2023<\/b><\/p>\n (unaudited, in millions, except per share data)<\/i><\/p>\n<\/td>\n<\/tr>\n\n| \n Item Description<\/b><\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n Segment<\/b><\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n Line Item<\/b><\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n Amount<\/b><\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n Tax Effect(1)<\/sup><\/b><\/p>\n<\/td>\n | \n\n \n\u00a0<\/p>\n<\/td>\n | \n After Tax<\/b><\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n EPS Impact<\/b><\/p>\n<\/td>\n<\/tr>\n\n| \n \nAccrued legal costs related to SEC investigation<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \nCorporate and Other<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \nOther operating expense<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n$<\/p>\n<\/td>\n | \n \n(0.2<\/p>\n<\/td>\n | \n \n)<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n$<\/p>\n<\/td>\n | \n \n\u2014<\/p>\n<\/td>\n | | \n\n \n\u00a0<\/p>\n<\/td>\n | \n \n$<\/p>\n<\/td>\n | \n \n(0.2<\/p>\n<\/td>\n | \n \n)<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n$<\/p>\n<\/td>\n | \n \n\u2014<\/p>\n<\/td>\n | | <\/tr>\n<\/table>\n\n\n| \n Special Items Impacting the Fiscal Year Ended Sept. 30, 2024<\/b><\/p>\n (unaudited, in millions, except per share data)<\/i><\/p>\n<\/td>\n<\/tr>\n\n| \n Item Description<\/b><\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n Segment<\/b><\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n Line Item<\/b><\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n Amount<\/b><\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n Tax Effect(1)<\/sup><\/b><\/p>\n<\/td>\n| \n \n\u00a0<\/p>\n<\/td>\n | \n After Tax<\/b><\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n EPS Impact<\/b><\/p>\n<\/td>\n<\/tr>\n\n| \n \nRestructuring charges(2)<\/sup><\/p>\n<\/td>\n| \n \n\u00a0<\/p>\n<\/td>\n | \n \nCorporate and Other<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \nOther operating expense<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n$<\/p>\n<\/td>\n | \n \n14.8<\/p>\n<\/td>\n | | \n\n \n\u00a0<\/p>\n<\/td>\n | \n \n$<\/p>\n<\/td>\n | \n \n\u2014<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n$<\/p>\n<\/td>\n | \n \n14.8<\/p>\n<\/td>\n | | \n\n \n\u00a0<\/p>\n<\/td>\n | \n \n$<\/p>\n<\/td>\n | \n \n0.36<\/p>\n<\/td>\n | | <\/tr>\n\n| \n \nRestructuring charges(2)<\/sup><\/p>\n<\/td>\n| \n \n\u00a0<\/p>\n<\/td>\n | \n \nSalt<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \nOther operating expense<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n0.4<\/p>\n<\/td>\n | | \n\n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u2014<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n0.4<\/p>\n<\/td>\n | | \n\n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n0.01<\/p>\n<\/td>\n | | <\/tr>\n\n| \n \nRestructuring charges(2)<\/sup><\/p>\n<\/td>\n| \n \n\u00a0<\/p>\n<\/td>\n | \n \nPlant Nutrition<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \nOther operating expense<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n0.6<\/p>\n<\/td>\n | | \n\n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u2014<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n0.6<\/p>\n<\/td>\n | | \n\n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n0.01<\/p>\n<\/td>\n | | <\/tr>\n\n| \n \nImpairments<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \nCorporate and Other<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \nCOGS and Loss on impairments<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n124.8<\/p>\n<\/td>\n | | \n\n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n124.8<\/p>\n<\/td>\n | | \n\n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n3.02<\/p>\n<\/td>\n | | <\/tr>\n \n| \n \nImpairments<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \nPlant Nutrition<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \nLoss on impairments<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n68.6<\/p>\n<\/td>\n | | \n\n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u2014<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n68.6<\/p>\n<\/td>\n | | \n\n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n1.66<\/p>\n<\/td>\n | | <\/tr>\n \n| \n \nProvision for product recall costs<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \nSalt<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \nOther operating expense<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n0.8<\/p>\n<\/td>\n | | \n\n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n(0.2<\/p>\n<\/td>\n | \n \n)<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n0.6<\/p>\n<\/td>\n | | \n\n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n0.01<\/p>\n<\/td>\n | | <\/tr>\n \n| \n \nTotal<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n$<\/p>\n<\/td>\n | \n \n210.0<\/p>\n<\/td>\n | | \n\n \n\u00a0<\/p>\n<\/td>\n | \n \n$<\/p>\n<\/td>\n | \n \n(0.2<\/p>\n<\/td>\n | \n \n)<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n$<\/p>\n<\/td>\n | \n \n209.8<\/p>\n<\/td>\n | | \n\n \n\u00a0<\/p>\n<\/td>\n | \n \n$<\/p>\n<\/td>\n | \n \n5.07<\/p>\n<\/td>\n | | <\/tr>\n<\/table>\n\n\n| \n Special Items Impacting the Fiscal Year Ended Sept. 30, 2023<\/b><\/p>\n (unaudited, in millions, except per share data)<\/i><\/p>\n<\/td>\n<\/tr>\n\n| \n Item Description<\/b><\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n Segment<\/b><\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n Line Item<\/b><\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n Amount<\/b><\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n Tax Effect(1)<\/sup><\/b><\/p>\n<\/td>\n| \n \n\u00a0<\/p>\n<\/td>\n | \n After Tax<\/b><\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n EPS Impact<\/b><\/p>\n<\/td>\n<\/tr>\n\n| \n \nRestructuring charges<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \nCorporate and Other<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \nOther operating expense<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n$<\/p>\n<\/td>\n | \n \n2.6<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n$<\/p>\n<\/td>\n | \n \n\u2014<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n$<\/p>\n<\/td>\n | \n \n2.6<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n$<\/p>\n<\/td>\n | \n \n0.07<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n<\/tr>\n | \n| \n \nRestructuring charges<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \nSalt<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \nCOGS and other operating expense<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n1.5<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n(0.1<\/p>\n<\/td>\n | \n \n)<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n1.4<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n0.04<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n<\/tr>\n | \n| \n \nRestructuring charges<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \nPlant Nutrition<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \nCOGS and other operating expense<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n1.4<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u2014<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n1.4<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n0.03<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n<\/tr>\n | \n| \n \nAccrued legal costs related to SEC investigation<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \nCorporate and Other<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \nOther operating expense<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n(0.3<\/p>\n<\/td>\n | \n \n)<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u2014<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n(0.3<\/p>\n<\/td>\n | \n \n)<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n(0.01<\/p>\n<\/td>\n | \n \n)<\/p>\n<\/td>\n<\/tr>\n | \n| \n \nTotal<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n$<\/p>\n<\/td>\n | \n \n5.2<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n$<\/p>\n<\/td>\n | \n \n(0.1<\/p>\n<\/td>\n | \n \n)<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n$<\/p>\n<\/td>\n | \n \n5.1<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n$<\/p>\n<\/td>\n | \n \n0.13<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n<\/tr>\n<\/table>\n \n\n| \n \n(1)<\/p>\n<\/td>\n | \n \nThere were no substantial income tax benefits related to these items given the U.S. valuation allowances on deferred tax assets The provision for product recall costs reflects an impact from Canadian taxes.<\/p>\n<\/td>\n<\/tr>\n | \n| \n \n(2)<\/p>\n<\/td>\n | \n \nRestructuring charges do not include certain reductions in stock-based compensation associated with forfeitures stemming from the restructuring activities. Amounts in the quarter ended Sept. 30, 2024, reflect the reversal of certain previously recognized costs related to the terminated lithium program after outstanding purchase commitments were finalized.<\/p>\n<\/td>\n<\/tr>\n<\/table>\n \n\n| \n Reconciliation for Adjusted Operating (Loss) Earnings<\/b><\/p>\n (unaudited, in millions)<\/i><\/p>\n<\/td>\n<\/tr>\n\n| \n \n\u00a0<\/p>\n<\/td>\n | \n Three months ended<\/b><\/p>\n Sept. 30,<\/b><\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n Twelve months ended<\/b><\/p>\n Sept. 30,<\/b><\/p>\n<\/td>\n<\/tr>\n\n| \n \n\u00a0<\/p>\n<\/td>\n | \n 2024<\/b><\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n 2023<\/b><\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n 2024<\/b><\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n 2023<\/b><\/p>\n<\/td>\n<\/tr>\n\n| \n \nOperating (loss) earnings<\/p>\n<\/td>\n | \n \n$<\/p>\n<\/td>\n | \n \n(29.8<\/p>\n<\/td>\n | \n \n)<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n$<\/p>\n<\/td>\n | \n \n2.2<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n$<\/p>\n<\/td>\n | \n \n(116.8<\/p>\n<\/td>\n | \n \n)<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n$<\/p>\n<\/td>\n | \n \n77.4<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n<\/tr>\n | \n| \n \nRestructuring charges(1)<\/sup><\/p>\n<\/td>\n| \n \n\u00a0<\/p>\n<\/td>\n | \n \n(1.4<\/p>\n<\/td>\n | \n \n)<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u2014<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n.<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n15.8<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n5.5<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n<\/tr>\n | \n| \n \nLoss on impairments(2)<\/sup><\/p>\n<\/td>\n| \n \n\u00a0<\/p>\n<\/td>\n | \n \n17.6<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u2014<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n.<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n193.4<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u2014<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n<\/tr>\n | \n| \n \nProvision for product recall costs(3)<\/sup><\/p>\n<\/td>\n| \n \n\u00a0<\/p>\n<\/td>\n | \n \n0.8<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u2014<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n.<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n0.8<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u2014<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n<\/tr>\n | \n| \n \nAccrued loss and legal costs related to SEC investigation(4)<\/sup><\/p>\n<\/td>\n| \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u2014<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n(0.2<\/p>\n<\/td>\n | \n \n)<\/p>\n<\/td>\n | \n \n.<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u2014<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n\u00a0<\/p>\n<\/td>\n | \n \n(0.3<\/p>\n<\/td>\n | \n \n)<\/p>\n<\/td>\n<\/tr>\n | \n| \n | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |